Treatment practices vary for lentigo maligna (LM). Staged excision with circumferential margin control (SECMC) has the potential to achieve low recurrence rates.
Objectives
To evaluate the clinical outcomes of SECMC using permanent, paraffin-embedded sections and delayed reconstruction.
Methods
We conducted a retrospective, uncontrolled, observational cohort study involving patients who underwent staged excision for LM of the head and neck at Women’s College Hospital in Toronto, Canada, from September 2010 to March 2013. Recurrence and infection rates were ascertained from patient charts and postal surveys.
Results
One hundred and two patients (45 female, 57 male) were included with a median follow-up time of 1410.5 (IQR 260-1756) days. The median age was 69 (IQR 61-79) years. Approximately one-fifth (21%, 21/102) of patients required greater than 0.5 cm margins to achieve histological clearance. One patient (1/102) upstaged to invasive melanoma based on the initial stage of excision. The infection rate was 6% (6/102) and the 5-year cumulative recurrence rate was 1.4% (95% CI 0.2-9.6%).
Conclusion
SECMC using permanent sections and delayed reconstruction appears to be a safe and effective treatment method for LM on the head and neck. Randomized trials are needed to help define the optimal treatment.
SwetterSM.BoldrickJC.JungSY.EgbertBM.HarvellJD. Increasing incidence of lentigo maligna melanoma subtypes: Northern California and national trends 1990-2000. J Invest Dermatol. 2005;125(4):685-691.doi:10.1111/j.0022-202X.2005.23852.x16185266
2.
ToenderA.KjærSK.JensenA. Increased incidence of melanoma in situ in Denmark from 1997 to 2011: results from a nationwide population-based study. Melanoma Res. 2014;24(5):488-495.doi:10.1097/CMR.000000000000009224892956
3.
GrevelingK.WakkeeM.NijstenT.van den BosRR.HollesteinLM. Epidemiology of Lentigo Maligna and Lentigo Maligna Melanoma in the Netherlands, 1989-2013. J Invest Dermatol. 2016;136(10):1955-1960.doi:10.1016/j.jid.2016.06.01427349862
4.
CooryM.BaadeP.AitkenJet al. Trends for in situ and invasive melanoma in Queensland, Australia, 1982-2002. Cancer Causes Control. 2006;17(1):21-27.doi:10.1007/s10552-005-3637-416411049
5.
GuiteraP.CollgrosH.MadronioCMet al. The steadily growing problem of lentigo maligna and lentigo maligna melanoma in Australia: population-based data on diagnosis and management. Australas J Dermatol. 2019;60(2):118-125.doi:10.1111/ajd.1292830302753
6.
Cancer SocietyA. Cancer Facts and Figures 2010. American Cancer Society; 2010.
7.
BrunssenA.JansenL.EisemannNet al. A population-based registry study on relative survival from melanoma in Germany stratified by tumor thickness for each histologic subtype. J Am Acad Dermatol. 2019;80(4):938-946.doi:10.1016/j.jaad.2018.09.01830244061
8.
FixW.EtzkornJR.ShinTMet al. Melanomas of the head and neck have high local recurrence risk features and require tissue rearranging reconstruction more commonly than BCCbcc and SCC: a comparison of indications for microscopic margin control prior to reconstruction in 13,664 tumors. J Am Acad Dermatol. 2018;S0190-9622(18):32910-4.doi:10.1016/j.jaad.2018.11.02030458206
9.
ShinTM.EtzkornJR.SobankoJFet al. Clinical factors associated with subclinical spread of in situ melanoma. J Am Acad Dermatol. 2017;76(4):707-713.doi:10.1016/j.jaad.2016.10.04928073583
10.
LiuA.BotkinA.MurrayCet al. Treatment for lentigo maligna of the head and neck: survey of practices in Ontario, Canada. Dermatol Surg. 2018;44(7):918-923.doi:10.1097/DSS.000000000000149829543619
11.
TzellosT.KyrgidisA.MocellinS.ChanA-W.PilatiP.ApallaZ. Interventions for melanoma in situ, including lentigo maligna. Cochrane Database Syst Rev. 2014;12:CD010308.doi:10.1002/14651858.CD010308.pub225526608
12.
DummerRHauschildALindenblattNPentheroudakisGKeilholzUESMO Guidelines Committee. Cutaneous melanoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26 Suppl 5(Suppl 5):v126-v132.doi:10.1093/annonc/mdv29726314774
SwetterSM.TsaoH.BichakjianCKet al. Guidelines of care for the management of primary cutaneous melanoma. J Am Acad Dermatol. 2019;80(1):208-250.doi:10.1016/j.jaad.2018.08.05530392755
15.
CoitDG.ThompsonJA.AlbertiniMRet al. Cutaneous melanoma, version 2.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2019;17(4):367-402.doi:10.6004/jnccn.2019.001830959471
16.
StigallLE.BrodlandDG.ZitelliJA. The use of Mohs micrographic surgery (MMS) for melanoma in situ (mis) of the trunk and proximal extremities. J Am Acad Dermatol. 2016;75(5):1015-1021.doi:10.1016/j.jaad.2016.06.03327473456
17.
ChristensenKN.HochwaltPC.HockerTLet al. Comparison of MITF and melan-A immunohistochemistry during mohs surgery for lentigo maligna-Type melanoma in situ and lentigo maligna melanoma. Dermatol Surg. 2016;42(2):167-175.doi:10.1097/DSS.000000000000060026771682
18.
Gaudy-MarquesteC.PerchenetA-S.TaséiA-Met al. The “Spaghetti technique”: an alternative to Mohs surgery or staged surgery for problematic lentiginous melanoma (lentigo maligna and acral lentiginous melanoma). J Am Acad Dermatol. 2011;64(1):113-118.doi:10.1016/j.jaad.2010.03.01421167406
19.
PatelAN.PerkinsW.LeachIH.VarmaS. Johnson square procedure for lentigo maligna and lentigo maligna melanoma. Clin Exp Dermatol. 2014;39(5):570-576.doi:10.1111/ced.1236324934910
20.
JohnsonTM.HeadingtonJT.BakerSR.LoweL. Usefulness of the staged excision for lentigo maligna and lentigo maligna melanoma: the “square” procedure. J Am Acad Dermatol. 1997;37(5 Pt 1):758-764.doi:10.1016/S0190-9622(97)70114-29366823
21.
AndersonKW.BakerSR.LoweL.SuL.JohnsonTM. Treatment of head and neck melanoma, lentigo maligna subtype: a practical surgical technique. Arch Facial Plast Surg. 2001;3(3):202-206.doi:10.1001/archfaci.3.3.20211497507
22.
MahoneyM-H.JosephM.TempleCLF. The perimeter technique for lentigo maligna: an alternative to Mohs micrographic surgery. J Surg Oncol. 2005;91(2):120-125.doi:10.1002/jso.2028416028282
23.
BosbousMW.DzwierzynskiWW.NeuburgM. Staged excision of lentigo maligna and lentigo maligna melanoma: a 10-year experience. Plast Reconstr Surg. 2009;124(6):1947-1955.doi:10.1097/PRS.0b013e3181bcf00219952650
24.
JejurikarSS.BorschelGH.JohnsonTM.LoweL.BrownDL. Immediate, optimal reconstruction of facial lentigo maligna and melanoma following total peripheral margin control. Plast Reconstr Surg. 2007;120(5):1249-1255.doi:10.1097/01.prs.0000279324.35616.7217898597
25.
LeeMR.RymanWJ. Treatment of lentigo maligna with total circumferential margin control using vertical and horizontal permanent sections: a retrospective study. Australas J Dermatol. 2008;49(4):196-201.doi:10.1111/j.1440-0960.2008.00468.x18855780
26.
de VriesK.GrevelingK.PrensLMet al. Recurrence rate of lentigo maligna after micrographically controlled staged surgical excision. Br J Dermatol. 2016;174(3):588-593.doi:10.1111/bjd.1432526616840
27.
AbdelmalekM.LoosemoreMP.HurtMA.HruzaG. Geometric staged excision for the treatment of lentigo maligna and lentigo maligna melanoma: a long-term experience with literature review. Arch Dermatol. 2012;148(5):599-604.doi:10.1001/archdermatol.2011.215522782151
28.
MoyerJS.RudyS.BoonstraPSet al. Efficacy of staged excision with permanent section margin control for cutaneous head and neck melanoma. JAMA Dermatol. 2017;153(3):282-288.doi:10.1001/jamadermatol.2016.460328002553
29.
BeveridgeJ.TaherM.ZhuJ.MahmoodMN.SalopekTG. Staged margin-controlled excision (SMEX) for lentigo maligna melanoma in situ. J Surg Oncol. 2018;118(1):144-149.doi:10.1002/jso.2510929936706
30.
KassiK.VanwijckR.KangaJ-M. The “collerette” technique for skin excision and biopsy: an efficient method for managing lentigo maligna of the head and neck. Int J Dermatol. 2014;53(7):899-903.doi:10.1111/ijd.1243024372370
31.
MöllerMG.Pappas-PolitisE.ZagerJSet al. Surgical management of melanoma-in-situ using a staged marginal and central excision technique. Ann Surg Oncol. 2009;16(6):1526-1536.doi:10.1245/s10434-008-0239-x19050971
32.
McKennaJK.FlorellSR.GoldmanGD.BowenGM. Lentigo maligna/lentigo maligna melanoma: current state of diagnosis and treatment. Dermatol Surg. 2006;32(4):493-504.doi:10.1111/j.1524-4725.2006.32102.x16681656
33.
Agarwal-AntalN.BowenGM.GerwelsJW. Histologic evaluation of lentigo maligna with permanent sections: implications regarding current guidelines. J Am Acad Dermatol. 2002;47(5):743-748.doi:10.1067/mjd.2002.12408512399768
34.
ZitelliJA.BrownCD.HanusaBH. Surgical margins for excision of primary cutaneous melanoma. J Am Acad Dermatol. 1997;37(3 Pt 1):422-429.doi:10.1016/S0190-9622(97)70144-09308558
35.
KunishigeJH.BrodlandDG.ZitelliJA. Surgical margins for melanoma in situ. J Am Acad Dermatol. 2012;66(3):438-444.doi:10.1016/j.jaad.2011.06.01922196979
36.
KunishigeJH.DoanL.BrodlandDG.ZitelliJA. Comparison of surgical margins for lentigo maligna versus melanoma in situ. J Am Acad Dermatol. 2019;81(1):204-212.
Kimyai-AsadiA.KatzT.GoldbergLHet al. Margin involvement after the excision of melanoma in situ: the need for complete en face examination of the surgical margins. Dermatol Surg. 2007;33(12):1434-1439.doi:10.1111/j.1524-4725.2007.33313.x18076608
39.
LeeMP.SobankoJF.ShinTMet al. Evolution of excisional surgery practices for melanoma in the United States. JAMA Dermatol. 2019;155(11):1244-1251.doi:10.1001/jamadermatol.2019.234631461124
40.
OsborneJE.HutchinsonPE. A follow-up study to investigate the efficacy of initial treatment of lentigo maligna with surgical excision. Br J Plast Surg. 2002;55(8):611-615.doi:10.1054/bjps.2002.396712550112
41.
TsangRW.LiuFF.WellsW.PayneDG. Lentigo maligna of the head and neck. Results of treatment by radiotherapy. Arch Dermatol. 1994;130(8):1008-1012.8053696
42.
ColemanWP.DavisRS.ReedRJ.KrementzET. Treatment of lentigo maligna and lentigo maligna melanoma. J Dermatol Surg Oncol. 1980;6(6):476-479.doi:10.1111/j.1524-4725.1980.tb00900.x7391322
43.
PitmanGH.KopfAW.BartRS.CassonPR. Treatment of lentigo maligna and lentigo maligna melanoma. J Dermatol Surg Oncol. 1979;5(9):727-737.doi:10.1111/j.1524-4725.1979.tb00016.x489814
44.
HouJL.ReedKB.KnudsonRMet al. Five-Year outcomes of wide excision and Mohs micrographic surgery for primary lentigo maligna in an academic practice cohort. Dermatol Surg. 2015;41(2):211-218.doi:10.1097/DSS.000000000000024825590473
45.
AkhtarS.BhatW.MagdumA.StanleyPRW. Surgical excision margins for melanoma in situ. J Plast Reconstr Aesthet Surg. 2014;67(3):320-323.doi:10.1016/j.bjps.2013.11.01424444795
46.
HealCF.BuettnerPG.DrobetzH. Risk factors for surgical site infection after dermatological surgery. Int J Dermatol. 2012;51(7):796-803.doi:10.1111/j.1365-4632.2011.05189.x22715823
47.
LiuX.SprengersM.NelemansPJ.MosterdK.Kelleners-SmeetsNWJ. Risk factors for surgical site infections in dermatological surgery. Acta Derm Venereol. 2018;98(2):246-250.doi:10.2340/00015555-284429136259
SmithH.BorchardK.CherianP.TaiY.VinciulloC. Randomized controlled trial of preoperative topical decolonization to reduce surgical site infection for Staphylococcus aureus nasal Swab-Negative Mohs micrographic surgery patients. Dermatol Surg. 2019;45(2):229-233.doi:10.1097/DSS.000000000000166230204741
50.
BasuP.GoldenbergA.CowanN.EilersR.HauJ.JiangSIB. A 4-year retrospective assessment of postoperative complications in immunosuppressed patients following Mohs micrographic surgery. J Am Acad Dermatol. 2019;80(6):1594-1601.doi:10.1016/j.jaad.2018.11.03230502411
51.
BariO.EilersRE.RubinAG.JiangSIB. Clinical characteristics of lower extremity surgical site infections in dermatologic surgery based upon 24-month retrospective review. J Drugs Dermatol. 2018;17(7):766-771.30005099
52.
NasseriE. Prospective study of wound infections in Mohs micrographic surgery using a single set of instruments. Dermatol Surg. 2015;41(9):1-1012.doi:10.1097/DSS.000000000000045826230327
53.
SmithH.BorchardK.CherianP.VinciulloC. Systematic review and meta-analysis of surgical site infection following Mohs surgery without prophylactic antibiotics. Australas J Dermatol. 2019;60(4):340-342.doi:10.1111/ajd.1306131034101
54.
WilsonJB.WallingHW.ScuphamRK.BeanAK.CeilleyRI.GoetzKE. Staged excision for lentigo maligna and lentigo maligna melanoma: analysis of surgical margins and long-term recurrence in 68 cases from a single practice. J Clin Aesthet Dermatol. 2016;9(6):25-30.27386048
55.
ChenC-SJ.EliasM.BusamK.RajadhyakshaM.MarghoobAA. Multimodal in vivo optical imaging, including confocal microscopy, facilitates presurgical margin mapping for clinically complex lentigo maligna melanoma. Br J Dermatol. 2005;153(5):1031-1036.doi:10.1111/j.1365-2133.2005.06831.x16225620
